TEVA PHARMACEUTICAL INDUSTRIES LTD Insider Trading for March 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD for March 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Option Exercise | M | 0.00 | 944 | 0 | 0 | |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Sell | S | 7.16 | 944 | 6,762 | 0 | 944 to 0 (-100.00 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Buy | M | 0.00 | 944 | 0 | 944 | 0 to 944 |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Option Exercise | M | 0.00 | 2,359 | 0 | 0 | |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Sell | S | 7.16 | 2,359 | 16,899 | 2,974 | 5.3 K to 3 K (-44.23 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Buy | M | 0.00 | 2,359 | 0 | 5,333 | 3 K to 5.3 K (+79.32 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Option Exercise | M | 0.00 | 1,179 | 0 | 0 | |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Sell | S | 7.16 | 470 | 3,367 | 14,868 | 15.3 K to 14.9 K (-3.06 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Buy | M | 0.00 | 1,179 | 0 | 15,338 | 14.2 K to 15.3 K (+8.33 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Option Exercise | M | 0.00 | 874 | 0 | 0 | |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Sell | S | 7.17 | 345 | 2,474 | 19,844 | 20.2 K to 19.8 K (-1.71 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Buy | M | 0.00 | 874 | 0 | 20,189 | 19.3 K to 20.2 K (+4.52 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 266 | 0 | 0 | |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 748 | 0 | 0 | |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 7.16 | 134 | 960 | 45,561 | 45.7 K to 45.6 K (-0.29 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 7.16 | 380 | 2,722 | 45,695 | 46.1 K to 45.7 K (-0.82 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 266 | 0 | 46,075 | 45.8 K to 46.1 K (+0.58 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 748 | 0 | 45,809 | 45.1 K to 45.8 K (+1.66 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Option Exercise | M | 0.00 | 1,179 | 0 | 0 | |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Buy | M | 0.00 | 1,179 | 0 | 20,639 | 19.5 K to 20.6 K (+6.06 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Option Exercise | M | 0.00 | 1,297 | 0 | 0 | |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Sell | S | 7.17 | 616 | 4,418 | 10,400 | 11 K to 10.4 K (-5.59 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Buy | M | 0.00 | 1,297 | 0 | 11,016 | 9.7 K to 11 K (+13.34 %) |
| Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Option Exercise | M | 0.00 | 4,807 | 0 | 14,424 | |
| Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Sell | S | 11.23 | 4,807 | 53,980 | 0 | 4.8 K to 0 (-100.00 %) |
| Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Buy | M | 0.00 | 4,807 | 0 | 4,807 | 0 to 4.8 K |
| Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Option Exercise | M | 0.00 | 1,166 | 0 | 1,166 | |
| Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Sell | S | 11.37 | 463 | 5,262 | 14,159 | 14.6 K to 14.2 K (-3.17 %) |
| Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Buy | M | 0.00 | 1,166 | 0 | 14,622 | 13.5 K to 14.6 K (+8.67 %) |
| Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Option Exercise | M | 0.00 | 1,399 | 0 | 1,400 | |
| Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Sell | S | 11.77 | 548 | 6,448 | 19,315 | 19.9 K to 19.3 K (-2.76 %) |
| Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Buy | M | 0.00 | 1,399 | 0 | 19,863 | 18.5 K to 19.9 K (+7.58 %) |
| Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Option Exercise | M | 0.00 | 1,399 | 0 | 1,400 | |
| Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Buy | M | 0.00 | 1,399 | 0 | 19,460 | 18.1 K to 19.5 K (+7.75 %) |
| Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Option Exercise | M | 0.00 | 2,098 | 0 | 2,101 | |
| Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Sell | S | 11.77 | 991 | 11,660 | 9,719 | 10.7 K to 9.7 K (-9.25 %) |
| Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Buy | M | 0.00 | 2,098 | 0 | 10,710 | 8.6 K to 10.7 K (+24.36 %) |
| Mar 04 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Option Exercise | M | 0.00 | 1,166 | 0 | 1,166 | |
| Mar 04 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Option Exercise | M | 0.00 | 2,941 | 0 | 5,882 | |
| Mar 04 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Sell | S | 11.37 | 1,166 | 13,253 | 0 | 1.2 K to 0 (-100.00 %) |
| Mar 04 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Buy | M | 0.00 | 1,166 | 0 | 1,166 | 0 to 1.2 K |
| Mar 04 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Sell | S | 11.60 | 2,941 | 34,112 | 0 | 2.9 K to 0 (-100.00 %) |
| Mar 04 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Buy | M | 0.00 | 2,941 | 0 | 2,941 | 0 to 2.9 K |
| Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Option Exercise | A | 0.00 | 73,720 | 0 | 73,720 | |
| Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | Schultz Kare | President and CEO | Option Exercise | A | 0.00 | 260,190 | 0 | 260,190 | |
| Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Option Exercise | A | 0.00 | 82,393 | 0 | 82,393 | |
| Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Option Exercise | A | 0.00 | 99,739 | 0 | 99,739 | |
| Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Option Exercise | A | 0.00 | 60,711 | 0 | 60,711 | |
| Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | Kalif Eliyahu Sharon | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 73,720 | 0 | 73,720 | |
| Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Option Exercise | A | 0.00 | 21,459 | 0 | 21,459 | |
| Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | A | 0.00 | 86,730 | 0 | 86,730 | |
| Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Option Exercise | A | 0.00 | 78,057 | 0 | 78,057 | |
| Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Option Exercise | A | 0.00 | 69,384 | 0 | 69,384 | |
| Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Option Exercise | A | 0.00 | 82,393 | 0 | 82,393 |